Oration has released its prescription drug management software, at the same time disclosing $11.2m in series A funding from backers including GV.

Kaiser Permanente has invested $10m in the communications platform as part of a $15m round that lifted its total funding to $163m.

Texas spinout Microtransponder raises $5.5m as it successfully completes a trial for a treatment for stroke patients.

Two years after its launch, venture firm Seventure has closed its Health for Life Capital fund at $175m after Novartis joined a raft of existing corporate partners.

Wuxi PharmaTech is anchor investor in the fund, which will target early-stage life science and healthcare investments in China and the US.

Norwest Venture Partners led the behavioural therapy provider's first publicly disclosed funding round, which will support its US expansion.

A possible cancer treatment that targets the uncontrolled growth of cancer cells gains a boost as a $15m investment sets it up for phase 1 clinical trials.